Clinical Trial

Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial

Study acronym: TEA-TIME
Recruiting
View on ClinicalTrials.gov →
Summary
Time-restricted eating - where no food is consumed over a period of time - has been shown to promote weight loss and improve cardio-metabolic function. In individuals with type 2 diabetes, it is also been shown to improve glucose control. The investigators propose a randomized controlled trial to determine whether time-restricted eating is an effective therapeutic strategy that can preserve pancreatic beta-cell function and improve glycemic control early in participants with type 2 diabetes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-26.
Status change: Not Yet Recruiting → Recruiting 2026-02-09
Trial Details
NCT Number NCT07272460
Lead Sponsor Mount Sinai Hospital, Canada
Conditions Type 2 Diabetes, Overweight (BMI > 25)
Enrollment 112 participants
Start Date 2026-02-01
Primary Completion 2029-03-30 (estimated)
Study Completion 2029-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-11